Volanesorsen

FDA Advisory Committee Votes in Favor of Waylivra for Treatment of Familial Chylomicronemia Syndrome
CP Wire
Fri, 05/11/18 - 10:09 am
Akcea Therapeutics
Ionis Pharmaceuticals
FDA
advisory panel
Waylivra
Volanesorsen
FCS
Outlook for Ionis, Akcea drug marred by safety concerns
Biopharma Dive
Wed, 05/9/18 - 09:25 pm
Ionis Pharmaceuticals
Akcea Therapeutics
FDA
advisory panel
Volanesorsen
3 Small-Cap Biotech Stocks With Big Catalysts in May
Motley Fool
Mon, 04/30/18 - 09:16 pm
Achaogen
plazomicin
Akcea Therapeutics
Volanesorsen
Portola Pharmaceuticals
AndexXa
Ionis-spinout Akcea prices IPO below expected range
Drug Delivery Business News
Sat, 07/15/17 - 11:23 am
Akcea
Ionis
IPOs
Volanesorsen
Ionis’s Orphan Drug in Third Phase of Clinical Trials
Market Realist
Thu, 09/22/16 - 09:07 am
Ionis Pharmaceuticals
clinical trials
orphan drugs
Volanesorsen